Pharmaceutical Technology Editors

Researchers at Massachusetts recently reported on the development of a drug-eluting contact lens designed to provide prolonged delivery of the glaucoma medication, latanoprost.

Novasep expands its presence in India with the opening of Novasep Process Engineering Services, a part of its industrial business unit.

Standards for ferrules and cap overseals focus on explicit warnings.

FDA cites cGMP violations and data-integrity issues and raises concerns over the company's ability to implement a robust and sustainable quality system.

Alvotech plans investment in biosimilars portfolio and manufacturing facility.

The flexible biomanufacturing system uses single-use technology.

Jill E. Sackman, D.V.M., PhD, senior consultant at Numerof & Associates, Inc. discusses the market forces impacting biopharmaceutical manufacturing

PharmaCheck, a portable tool designed to detect poor-quality medicines, has been selected by Scientific American as one of the magazine?s World Changing Ideas of 2013.

LSNE appoints Shawn Cain as COO, a new position within the company.

Facility in Germany provides space for evaluating continuous pharmaceutical processing equipment.

A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.

EMA revises its polices on fee reductions for orphan drugs for 2014.

SGS Life Science Services announced that its bioanalytical laboratory in Poitiers, France has received GMP certification, following approval from ANSM.

Aptuit appoints Jonathan Goldman as CEO.

American Association of Pharmaceutical Scientists Foundation to assist current and future scientists.

EMA hosted a workshop on Nov. 26, 2013, which brought together regulators, health-technology-assessment (HTA) bodies and the pharmaceutical industry to discuss how to generate evidence in drug development and improve medicines access.

Drug Quality and Security Act gives FDA authority over compounding pharmacies.

The international “Fight the Fakes” campaign will raise awareness about the dangers of counterfeit medicines.

Baxter has issued a voluntary recall of one lot of nitroglycerin in 5% dextrose injection after particulate matter was found in one vial.

Novartis reports on the discovery of phosphatidylinositol-4 kinase (PfPI4K) as the target of a class of experimental antimalarial drugs called the imidazopyrazines, which has the potential to prevent, block and treat multiple stages of the malaria lifecycle.

Additional companies join Merck KGaA and Neviah Genomics in the Israel BioIncubator.

The Indiana Biosciences Research Institute will accelerate collaboration and focus on human-health solutions.

Catalent opens clinical-trial supply facility in Shanghai, China.

Baxter and Cell Therapeutics enter a licensing agreement to develop and commercialize pacritinib.

Thermo Fisher must divest of cell culture media and sera lines, and other businesses, in purchase of Life Technologies.

Almac releases an enhanced third-party logistics customer billing application.

Harlan Korea appoints Kwan Goo Edmond (Ed) Cho as its new president.

Pure MHC and Catalent sign an agreement to develop RL21A using Catalent's GPEx technology.

Stada licenses 3M's transdermal technology for a fentanyl patch.

Mylan and the Indian biopharmaceutical company Biocon receive approval for a biosimilar version of trastuzumab in India. Also, Mylan and Teva reach settlement on Copaxone in the EU.